| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2107124 | Cancer Cell | 2012 | 4 Pages |
Abstract
Two recent papers published in Nature demonstrate the power of systematic high-throughput pharmacologic profiling of very large, diverse, molecularly-characterized human cancer cell line panels to reveal linkages between genetic profile and targeted-drug sensitivity. Known oncogene addictions are confirmed while surprising complexities and biomarker relationships with clinical potential are revealed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Paul Workman, Paul A. Clarke, Bissan Al-Lazikani,